Ermium presentation, at the ACR convergence 2023 conference, emphasizes the promise of its immunomodulators for SLE with robust efficacy data in a spontaneous lupus mouse model

Annegret Van der Aa, Ermium CSO/CDO, presented at ACR convergence 2023 conference held in San Diego (November 10 – 15) a poster entitled : “Functionally selective immunomodulator show robust efficacy in spontaneous lupus mouse model”, co-authored by Hélène Asnagli, Simon Tessier, Martyn Foster, Sofie Denies, Eef Hoeben, Joël Crouzet, and Annegret Van der Aa.

The presented study highlights the solid and promising results of Ermium therapeutic approach with a POC in a well-recognized animal mouse model of SLE.